Skip to main content
. Author manuscript; available in PMC: 2021 Jul 7.
Published in final edited form as: Gastroenterology. 2020 Mar 12;159(1):119–128.e2. doi: 10.1053/j.gastro.2020.03.014

Table 1.

Patient Baseline Characteristics

Characteristics and outcomes Endocut (n = 464) Forced coagulation (n = 464) P
Patients
 Age, y, mean (SD) 64.7 (9.7) 65.4 (9.5) .284
 Male sex, n (%) 276 (59.5) 276 (59.5) 1.0
 Race or ethnic group, n (%) .719
  Non-Hispanic white 414 (89.2) 407 (87.7)
  Non-Hispanic black 27 (5.8) 35 (7.5)
  Hispanic 13 (2.8) 14 (3.0)
  Asian 3 (0.6) 4 (0.9)
  Other/unknown 7 (1.5) 4 (0.9)
 Body mass index, kg/m2, mean (SD) 29.3 (6.4) 29.0 (5.6) .521
 ASA class, n (%) .718
  I 42 (9.1) 37 (8.0)
  II 259 (55.8) 254 (54.7)
  III 163 (35.1) 173 (37.3)
 Antithrombotic medications, n (%) 128 (27.6) 141 (30.4) .347
  Antiplatelet agents 115 (24.8) 117 (25.2) .879
  Anticoagulants 18 (4.0) 30 (6.6) .083
Procedure, n (%)
 Sedation .106
  No sedation 1 (0.2) 5 (1.1)
  Moderate sedation 65 (14.0) 51 (11.0)
  Monitored anesthesia care 398 (85.8) 408 (87.9)
 Quality of bowel preparation .797
  Excellent 126 (27.5) 123 (26.2)
  Good 256 (55.9) 273 (58.1)
  Fair 76 (16.6) 74 (15.7)
 Any additional polyp (any size), n (%) 201 (43.3) 207 (44.6) .692
 More than 1 ≥20 mm study polyp, n (%) 40 (8.6) 21 (4.5) .012

ASA, American Society of Anesthesiologists.